Development asset linked to vTv Therapeutics in public FDA and regional records.
pharma · Alzheimer's Disease · Type 2 Diabetes Mellitus · VTVT
vTv Therapeutics
vTv Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
3980 Premier Dr, Suite 110, High Point, North Carolina 27265, US HQ
55 Employees
Public company Type
VTVT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 3980 Premier Dr, Suite 110, High Point, North Carolina 27265, US
- Employees
- 55
- Programs
- 14
- Drugs
- 2
- Patents
- 50
vTv Therapeutics pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
vTv Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
human coagulation factor viii / human von willebrand factor
Blood and blood forming organs (B02)Blood and blood forming organs (B02) compound in vTv Therapeutics's portfolio.